Annual USC Update in GI and Liver Diseases: Controversies and Guidelines in 2026
Recent advances in gastroenterology and hepatology are transforming patient care. Novel therapies are improving outcomes for IBD, MASLD, Met-ALD, cholestatic liver diseases, and viral hepatitis, while innovations in endoscopy and imaging are reshaping the management of pancreaticobiliary disorders, motility disorders, and early GI neoplasia. Despite this progress, important clinical challenges and knowledge gaps remain. This conference ... Read more
